Report
Debbie Wang
EUR 100.00 For Business Accounts Only

Dexcom Sees a Mix of Factors Weighing on Profitability; No Change to Our FVE

While Dexcom’s strong first-quarter results slightly exceeded our expectations on the top line, this was offset by slightly falling short of our estimates on the bottom line. We’re leaving our fair value estimate unchanged, as Dexcom seems to be on track to hit our full-year projections. Robust adoption of the new G6 continuous glucose monitor fueled 52% quarterly revenue growth, with even stronger growth from international markets. However, gross margin fell by 430 basis points year over year. ...
Underlying
DEXCOM INC.

DexCom is a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring systems for use by people with diabetes and by healthcare providers. The company's products include: DecCom G6?, which allows the company's transmitter to run an algorithm to generate a glucose value and to communicate to a patient's mobile device; DexCom G4? PLATINUM, which is used to adjust therapy and to educate and motivate patients to modify their behavior after viewing the effects that specific foods, exercise, stress and medications have on their glucose levels; and DexCom Share?, which transmits glucose information to the mobile devices of designated recipients.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Debbie Wang

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch